Statins have been shown to be very effective and safe in numerous randomized clinical trials, and became the implacable first-line treatment against atherogenic dyslipidemia. However, even with optimal statin treatment, 60% to 80% of residual cardiovascular risk still exists. The patients with familial hypercholesterolemia which results in extremely high level of low density lipoprotein cholesterol (LDL-C) level and the patients who are intolerant or unresponsive to statins are the other hurdles of statin treatment. Recently, new classes of lipid-lowering drugs have been developed and some of them are available for the clinical practice. The pro-protein convertase subtilisin/kexintype 9 (PCSK9) inhibitor increases the expression of low density lipoprotein (LDL) receptor in hepatocytes by enhancing LDL receptor recycling. The microsomal triglyceride transport protein (MTP) inhibitor and antisense oligonucleotide against apolipoprotein B (ApoB) reduce the ApoB containing lipoprotein by blocking the hepatic very low density lipoprotein synthesis pathway. The apolipoprotein A1 (ApoA1) mimetics pursuing the beneficial effect of high density lipoprotein cholesterol and can reverse the course of atherosclerosis. ApoA1 mimetics had many controversial clinical data and need more validation in humans. The PCSK9 inhibitor recently showed promising results of significant LDL-C lowering in familial hypercholesterolemia (FH) patients from the long-term phase III trials. The MTP inhibitor and antisesnse oligonucleotide against ApoB were approved for the treatment of homozygous FH but still needs more consolidated evidences about hepatic safety such as hepatosteatosis. We would discuss the benefits and concerns of these new lipid-lowering drugs anticipating additional benefits beyond statin treatment.

Citations

Citations to this article as recorded by  

• Role of PCSK9 inhibitors in the management of dyslipidaemia
  Tiny Nair
  Indian Heart Journal.2024; 76: S44.     CrossRef
• Targeting Lipoprotein(a): Can RNA Therapeutics Provide the Next Step in the Prevention of Cardiovascular Disease?
  Henriette Thau, Sebastian Neuber, Maximilian Y. Emmert, Timo Z. Nazari-Shafti
  Cardiology and Therapy.2024; 13(1): 39.     CrossRef
• UHPLC Specific Method for Simultaneous Determination of Probable Impurities of Ezetimibeand Simvastatin in Combined Dosage Form
  Anantha Lakshmi Vadivelu, Sathapathy Panduranga Vittal, Duvvuri Suryakala
  Oriental Journal Of Chemistry.2024; 40(1): 228.     CrossRef
• LC‐MS based metabolite profiling, in‐vitro antioxidant and in‐vivo antihyperlipidemic activity of Nigella sativa extract
  Amit Kumar Shrivastava, Laxmi Shrestha, Buddhi Raj Pokhrel, Bishal Joshi, Gopal Lamichhane, Bojana Vidović, Niranjan Koirala
  eFood.2023;[Epub]     CrossRef
• Development of New Genome Editing Tools for the Treatment of Hyperlipidemia
  Giulio Preta
  Cells.2023; 12(20): 2466.     CrossRef
• High residual cardiovascular risk after lipid-lowering: prime time for Predictive, Preventive, Personalized, Participatory, and Psycho-cognitive medicine
  E. Reijnders, A. van der Laarse, J. W. Jukema, C. M. Cobbaert
  Frontiers in Cardiovascular Medicine.2023;[Epub]     CrossRef
• Riesgo residual. Conclusiones
  Ángel Cequier, José Luis Zamorano
  Revista Española de Cardiología Suplementos.2023; 23: 25.     CrossRef
• Anti-hyperglycemic, anti-hyperlipidemic, and anti-inflammatory effect of the drug Guggulutiktaka ghrita on high-fat diet-induced obese rats
  Samreen M. Sheik, Pugazhandhi Bakthavatchalam, Revathi P. Shenoy, Basavaraj S. Hadapad, Deepak Nayak M, Monalisa Biswas, Varashree Bolar Suryakanth
  Journal of Ayurveda and Integrative Medicine.2022; 13(3): 100583.     CrossRef
• New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
  Kyuho Kim, Henry N. Ginsberg, Sung Hee Choi
  Diabetes & Metabolism Journal.2022; 46(4): 517.     CrossRef
• A New Modality in Dyslipidemia Treatment: Antisense Oligonucleotide Therapy
  Kyuho Kim, Sung Hee Choi
  Journal of Lipid and Atherosclerosis.2022; 11(3): 250.     CrossRef
• Tyramine exerts hypolipidemic and anti-obesity effects in vivo
  Thamires Maria Fontenele Morais, Tiago Sousa Melo, Mariana Brito Dantas, Jamile Magalhães Ferreira, Daniel Freire de Sousa, Emanuel Paula Magalhães, Ramon Róseo Paula Pessoa Bezerra de Menezes, Otília Deusdênia Loiola Pessoa, Mariana Lima Feitosa, Francis
  Brazilian Journal of Pharmaceutical Sciences.2022;[Epub]     CrossRef
• Statin adherence and risk of all-cause, cancer, and cardiovascular mortality among dyslipidemia patients: A time-dependent analysis
  Young Ran Lee, Sarah Soyeon Oh, Sung-In Jang, Eun-Cheol Park
  Nutrition, Metabolism and Cardiovascular Diseases.2020; 30(12): 2207.     CrossRef
• Efficient reabsorption of transintestinally excreted cholesterol is a strong determinant for cholesterol disposal in mice
  Ivo P. van de Peppel, Anna Bertolini, Theo H. van Dijk, Albert K. Groen, Johan W. Jonker, Henkjan J. Verkade
  Journal of Lipid Research.2019; 60(9): 1562.     CrossRef
• Pharmacological Strategies beyond Statins: Ezetimibe and PCSK9 Inhibitors
  Jah Yeon Choi, Jin Oh Na
  Journal of Lipid and Atherosclerosis.2019; 8(2): 183.     CrossRef
• Effects of silymarin supplementation on blood lipids: A systematic review and meta‐analysis of clinical trials
  Hamed Mohammadi, Amir Hadi, Arman Arab, Sajjad Moradi, Mohammad Hossein Rouhani
  Phytotherapy Research.2019; 33(4): 871.     CrossRef
• Change in ALT levels after administration of HMG‐CoA reductase inhibitors to subjects with pretreatment levels three times the upper normal limit in clinical practice
  Hyunah Kim, Hyeseon Lee, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung‐Hwan Lee, Jae‐Hyoung Cho, Hyunyong Lee, Hyeon Woo Yim, In Young Choi, Kun‐Ho Yoon, Hun‐Sung Kim
  Cardiovascular Therapeutics.2018;[Epub]     CrossRef
• Host-targeting therapies for hepatitis C virus infection: current developments and future applications
  Emilie Crouchet, Florian Wrensch, Catherine Schuster, Mirjam B. Zeisel, Thomas F. Baumert
  Therapeutic Advances in Gastroenterology.2018; 11: 175628481875948.     CrossRef
• New and Future Parenteral Therapies for the Management of Lipid Disorders
  Roberto Garcia, Jaime Burkle
  Archives of Medical Research.2018; 49(8): 538.     CrossRef
• NEW DRUGS FOR THE TREATMENT OF DYSLIPIDEMIA
  Aleksandra Novaković, Marija Marinko, Ivan Stojanović, Dragoslav Nenezić, Predrag Milojević, Vladimir Kanjuh
  Acta Medica Medianae.2018; 57(1): 54.     CrossRef
• Effects of diethylene glycol dibenzoate and Bisphenol A on the lipid metabolism of Danio rerio
  Stefania Santangeli, Valentina Notarstefano, Francesca Maradonna, Elisabetta Giorgini, Giorgia Gioacchini, Isabel Forner-Piquer, Hamid R. Habibi, Oliana Carnevali
  Science of The Total Environment.2018; 636: 641.     CrossRef
• Cardiac autonomic neuropathy: Risk factors, diagnosis and treatment
  Victoria A Serhiyenko, Alexandr A Serhiyenko
  World Journal of Diabetes.2018; 9(1): 1.     CrossRef
• Krüppel-like factor 14, a coronary artery disease associated transcription factor, inhibits endothelial inflammation via NF-κB signaling pathway
  Wenting Hu, Haocheng Lu, Jifeng Zhang, Yanbo Fan, Ziyi Chang, Wenying Liang, Huilun Wang, Tianqing Zhu, Minerva T. Garcia-Barrio, Daoquan Peng, Y. Eugene Chen, Yanhong Guo
  Atherosclerosis.2018; 278: 39.     CrossRef
• Strategies for the use of nonstatin therapies
  Angela Pirillo, Giuseppe D. Norata, Alberico L. Catapano
  Current Opinion in Lipidology.2017; 28(6): 458.     CrossRef
• The efficacy advantage of evolocumab (AMG 145) dosed at 140 mg every 2 weeks versus 420 mg every 4 weeks in patients with hypercholesterolemia: Evidence from a meta-analysis
  Xiao-Xiao He, Rong Zhang, Pei-Yuan Zuo, Yu-Wei Liu, Xiang-Nan Zha, Sheng-Shuai Shan, Cheng-Yun Liu
  European Journal of Internal Medicine.2017; 38: 52.     CrossRef
• The Potential Therapeutic Application of Peptides and Peptidomimetics in Cardiovascular Disease
  Carlota Recio, Francesco Maione, Asif J. Iqbal, Nicola Mascolo, Vincenzo De Feo
  Frontiers in Pharmacology.2017;[Epub]     CrossRef
• Emerging biologic therapies for hypercholesterolaemia
  Giacomo Pucci, Arrigo F Cicero, Claudio Borghi, Giuseppe Schillaci
  Expert Opinion on Biological Therapy.2017; 17(9): 1077.     CrossRef
• ANMCO/ISS/AMD/ANCE/ARCA/FADOI/GICR-IACPR/SICI-GISE/SIBioC/SIC/SICOA/SID/SIF/SIMEU/SIMG/SIMI/SISA Joint Consensus Document on cholesterol and cardiovascular risk: diagnostic–therapeutic pathway in Italy
  Michele Massimo Gulizia, Furio Colivicchi, Gualtiero Ricciardi, Simona Giampaoli, Aldo Pietro Maggioni, Maurizio Averna, Maria Stella Graziani, Ferruccio Ceriotti, Alessandro Mugelli, Francesco Rossi, Gerardo Medea, Damiano Parretti, Maurizio Giuseppe Abr
  European Heart Journal Supplements.2017; 19(suppl_D): D3.     CrossRef
• Rev-erb regulation of cholesterologenesis
  Sadichha Sitaula, Jinsong Zhang, Fernanda Ruiz, Thomas P. Burris
  Biochemical Pharmacology.2017; 131: 68.     CrossRef
• Novel lipid modifying drugs to lower LDL cholesterol
  Arjen J. Cupido, Laurens F. Reeskamp, John J.P. Kastelein
  Current Opinion in Lipidology.2017; 28(4): 367.     CrossRef
• 2017 Position Paper of the Italian Society for Cardiovascular Prevention (SIPREC) for an Updated Clinical Management of Hypercholesterolemia and Cardiovascular Risk: Executive Document
  Massimo Volpe, Roberto Volpe, Giovanna Gallo, Vivianne Presta, Giuliano Tocci, Emanuela Folco, Andrea Peracino, Elena Tremoli, Bruno Trimarco
  High Blood Pressure & Cardiovascular Prevention.2017; 24(3): 313.     CrossRef
• Sobetirome: the past, present and questions about the future
  Jan Lammel Lindemann, Paul Webb
  Expert Opinion on Therapeutic Targets.2016; 20(2): 145.     CrossRef
• Role of growth hormone-releasing hormone in dyslipidemia associated with experimental type 1 diabetes
  Maritza J. Romero, Rudolf Lucas, Huijuan Dou, Supriya Sridhar, Istvan Czikora, Eby M. Mosieri, Ferenc G. Rick, Norman L. Block, Subbaramiah Sridhar, David Fulton, Neal L. Weintraub, Zsolt Bagi, Andrew V. Schally
  Proceedings of the National Academy of Sciences.2016; 113(7): 1895.     CrossRef
• Recent trends in and new data on the epidemiology and prevention of non-communicable diseases
  S. A. Boytsov
  Terapevticheskii arkhiv.2016; 88(1): 4.     CrossRef
• Cellular Model of Atherogenesis Based on Pluripotent Vascular Wall Pericytes
  Ekaterina A. Ivanova, Alexander N. Orekhov
  Stem Cells International.2016; 2016: 1.     CrossRef
• Pre-treatment with simvastatin prevents the induction of diet-induced atherosclerosis in a rabbit model
  Nikolaos Oikonomidis, Nikolaos Kavantzas, Laskarina-Maria Korou, Panagiotis Konstantopoulos, Vasilios Pergialiotis, Evangelos Misiakos, Ioannis Rizos, Christos Verikokos, Despina N. Perrea
  Biomedical Reports.2016; 5(6): 667.     CrossRef
• Prevention of oxLDL uptake leads to decreased atherosclerosis in hematopoietic NPC1-deficient Ldlr−/− mice
  Mike L.J. Jeurissen, Sofie M.A. Walenbergh, Tom Houben, Marion J.J. Gijbels, Jieyi Li, Tim Hendrikx, Yvonne Oligschlaeger, Patrick J. van Gorp, Christoph J. Binder, Marjo M.P.C. Donners, Ronit Shiri-Sverdlov
  Atherosclerosis.2016; 255: 59.     CrossRef

Patients with diabetes mellitus (DM) have accelerated atherosclerosis with an increased risk for atherothrombotic cardiovascular complications. A state of high platelet reactivity and activation, hypercoagulability (prothrombotic state) and a subdued response to standard antiplatelet agents may explain high rate of adverse cardiovascular events in patients with DM. Several antithrombotic treatment strategies have been developed to control the prothrombotic state in patients with DM: dose modification of commonly used agents; use of potent agents; and addition of a third antithrombotic drug (triple therapy) to commonly prescribed dual antiplatelet therapy of aspirin and a P2Y₁₂ inhibitor. The present review aims to provide an overview of the current knowledge on platelet abnormalities in patients with DM, focusing on the challenges and perspectives of antiplatelet treatment strategies in this population.

Citations

Citations to this article as recorded by  

• Mice expressing nonpolymerizable fibrinogen have reduced arterial and venous thrombosis with preserved hemostasis
  Woosuk S. Hur, Tomohiro Kawano, Jean Marie N. Mwiza, David S. Paul, Robert H. Lee, Emily G. Clark, Emma G. Bouck, Ananya Dutta, Can Cai, Stephen R. Baker, Martin Guthold, Nigel Mackman, Pierre Mangin, Alisa S. Wolberg, Wolfgang Bergmeier, Matthew J. Flick
  Blood.2024; 143(2): 105.     CrossRef
• On‐Treatment Platelet Reactivity and Ischemic Outcomes in Patients With Diabetes Mellitus: Two‐Year Results From ADAPT‐DES
  Bahira Shahim, Björn Redfors, Thomas D. Stuckey, Mengdan Liu, Zhipeng Zhou, Bernhard Witzenbichler, Giora Weisz, Michael J. Rinaldi, Franz‐Josef Neumann, D. Christopher Metzger, Timothy D. Henry, David A. Cox, Peter L. Duffy, Bruce R. Brodie, Iva Srdanovi
  Journal of the American Heart Association.2023;[Epub]     CrossRef
• Platelet Glycoprotein-Ib (GPIb) May Serve as a Bridge between Type 2 Diabetes Mellitus (T2DM) and Atherosclerosis, Making It a Potential Target for Antiplatelet Agents in T2DM Patients
  Muttia Amalia, Meidi Utami Puteri, Fadlina Chany Saputri, Rani Sauriasari, Bambang Widyantoro
  Life.2023; 13(7): 1473.     CrossRef
• Polymorphisms of genes related to phase II metabolism and resistance to clopidogrel
  Abdullah Alkattan, Ahmed Alkhalifah, Eman Alsalameen, Fatimah Alghanim, Nashwa Radwan
  Pharmacogenomics.2022; 23(1): 61.     CrossRef
• Prolonged dual antiplatelet therapy after drug-eluting stent implantation in patients with diabetes mellitus: A nationwide retrospective cohort study
  Seung-Jun Lee, Dong-Woo Choi, Choongki Kim, Yongsung Suh, Sung-Jin Hong, Chul-Min Ahn, Jung-Sun Kim, Byeong-Keuk Kim, Young-Guk Ko, Donghoon Choi, Eun-Cheol Park, Yangsoo Jang, Chung-Mo Nam, Myeong-Ki Hong
  Frontiers in Cardiovascular Medicine.2022;[Epub]     CrossRef
• New opportunities of antithrombotic therapy in patients with type 2 diabetes mellitus and stable coronary heart disease for reducing the cardiovascular risk and cardiovascular complications: THEMIS, THEMIS-PCI trials
  Victor I. Kalashnikov, Marina S. Michurova
  Terapevticheskii arkhiv.2022; 94(10): 1204.     CrossRef
• Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial
  Kyeong Ho Yun, Jae Young Cho, Seung Yul Lee, Sang Jae Rhee, Byeong Keuk Kim, Myeong Ki Hong, Yangsoo Jang, Seok Kyu Oh
  Frontiers in Pharmacology.2021;[Epub]     CrossRef
• Long-term outcomes of ischaemic stroke patients with diabetes in a multi-ethnic cohort in Singapore
  Ei Zune The, Mei Yen Ng, Geelyn JL Ng, Bernadette GC Er, Amy ML Quek, Prakash Paliwal, Leonard L Yeo, Bernard PL Chan, Vijay K Sharma, Hock Luen Teoh, Eric YH Khoo, Raymond CS Seet
  Annals of the Academy of Medicine, Singapore.2021; 50(1): 16.     CrossRef
• Protective Role of Platelets in Myocardial Infarction and Ischemia/Reperfusion Injury
  Kornela Hałucha, Alina Rak-Pasikowska, Iwona Bil-Lula, David J. Chambers
  Cardiology Research and Practice.2021; 2021: 1.     CrossRef
• Pre- and Post-Conditioning of the Heart: An Overview of Cardioprotective Signaling Pathways
  Denise Coutinho de Miranda, Gabriela de Oliveira Faria, Milla Marques Hermidorff, Fernanda Cacilda dos Santos Silva, Leonardo Vinícius Monteiro de Assis, Mauro César Isoldi
  Current Vascular Pharmacology.2021; 19(5): 499.     CrossRef
• Post-Transcriptional Expression Control in Platelet Biogenesis and Function
  Carolin T. Neu, Tony Gutschner, Monika Haemmerle
  International Journal of Molecular Sciences.2020; 21(20): 7614.     CrossRef
• The impact of metformin and aspirin on T-cell mediated inflammation: A systematic review of in vitro and in vivo findings
  Tawanda Maurice Nyambuya, Phiwayinkosi Vusi Dludla, Vuyolwethu Mxinwa, Kabelo Mokgalaboni, Siphamandla Raphael Ngcobo, Luca Tiano, Bongani Brian Nkambule
  Life Sciences.2020; 255: 117854.     CrossRef
• Short- versus long-term dual antiplatelet therapy after second-generation drug-eluting stent implantation in patients with diabetes mellitus: A meta-analysis of randomized controlled trials
  Hongyu Zhang, Junsong Ke, Jun Huang, Kai Xu, Yun Chen, Timir Paul
  PLOS ONE.2020; 15(12): e0242845.     CrossRef
• Long non-coding RNA metallothionein 1 pseudogene 3 promotes p2y12 expression by sponging miR-126 to activate platelet in diabetic animal model
  Ming Zhou, Meng Gao, Yanwei Luo, Rong Gui, Hongwen Ji
  Platelets.2019; 30(4): 452.     CrossRef
• Circulating blood cells and extracellular vesicles in acute cardioprotection
  Sean M Davidson, Ioanna Andreadou, Lucio Barile, Yochai Birnbaum, Hector A Cabrera-Fuentes, Michael V Cohen, James M Downey, Henrique Girao, Pasquale Pagliaro, Claudia Penna, John Pernow, Klaus T Preissner, Péter Ferdinandy
  Cardiovascular Research.2019; 115(7): 1156.     CrossRef
• Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention
  Kye Taek Ahn, Seok-Woo Seong, Ung Lim Choi, Seon-Ah Jin, Jun Hyung Kim, Jae-Hwan Lee, Si Wan Choi, Myung Ho Jeong, Shung Chull Chae, Young Jo Kim, Chong Jin Kim, Hyo-Soo Kim, Myeong-Chan Cho, Hyeon-Cheol Gwon, Jin-Ok Jeong, In-Whan Seong
  Medicine.2019; 98(11): e14833.     CrossRef
• Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
  Benjamin T. Maatman, Glen Schmeisser, Rolf P. Kreutz
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Role of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with coronary artery disease undergoing percutaneous coronary intervention
  Eliano P. Navarese, Michalina Kołodziejczak, Aniela Petrescu, Bernhard Wernly, Michael Lichtenauer, Alexander Lauten, Antonino Buffon, Wojciech Wanha, Vincenzo Pestrichella, Gennaro Sardella, Gaetano Contegiacomo, Udaya Tantry, Kevin Bliden, Jacek Kubica,
  Expert Review of Cardiovascular Therapy.2018; 16(6): 419.     CrossRef
• Cardioprotective Properties of Human Platelets Are Lost in Uncontrolled Diabetes Mellitus: A Study in Isolated Rat Hearts
  Isabella Russo, Saveria Femminò, Cristina Barale, Francesca Tullio, Stefano Geuna, Franco Cavalot, Pasquale Pagliaro, Claudia Penna
  Frontiers in Physiology.2018;[Epub]     CrossRef
• Aortic thrombosis in dogs
  Trevor P.E. Williams, Scott Shaw, Adam Porter, Larry Berkwitt
  Journal of Veterinary Emergency and Critical Care.2017; 27(1): 9.     CrossRef
• Challenges in Patients with Diabetes: Improving Clinical Outcomes After Percutaneous Coronary Intervention Through EVOlving Stent Technology
  Robert A Byrne, Shmuel Banai, Roisin Colleran, Antonio Colombo
  Interventional Cardiology Review.2017; 13(01): 40.     CrossRef
• Adding CABG to the Dual Antiplatelet Salad
  Glenn N. Levine, Faisal G. Bakaeen
  Journal of the American College of Cardiology.2017; 69(2): 128.     CrossRef
• The association between arterial stiffness and tongue manifestations of blood stasis in patients with type 2 diabetes
  Po-Chi Hsu, Yu-Chuen Huang, John Y. Chiang, Hen-Hong Chang, Pei-Yung Liao, Lun-Chien Lo
  BMC Complementary and Alternative Medicine.2016;[Epub]     CrossRef
• Platelet phenotype changes associated with breast cancer and its treatment
  Chris E. Holmes, Jamie E. Levis, David J. Schneider, Nadia M. Bambace, Deva Sharma, Inder Lal, Marie E. Wood, Hyman B. Muss
  Platelets.2016; 27(7): 703.     CrossRef

Citations

Citations to this article as recorded by  

• Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control
  Jee Hee Yoo, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2020; 44(6): 828.     CrossRef
• Glycemic variability in continuous glucose monitoring is inversely associated with baroreflex sensitivity in type 2 diabetes: a preliminary report
  Daisuke Matsutani, Masaya Sakamoto, Hiroyuki Iuchi, Souichirou Minato, Hirofumi Suzuki, Yosuke Kayama, Norihiko Takeda, Ryuzo Horiuchi, Kazunori Utsunomiya
  Cardiovascular Diabetology.2018;[Epub]     CrossRef
• The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus
  Gyuri Kim, Sewon Oh, Sang-Man Jin, Kyu Yeon Hur, Jae Hyeon Kim, Moon-Kyu Lee
  Expert Opinion on Pharmacotherapy.2017; 18(12): 1179.     CrossRef
• The association between glycemic variability and diabetic cardiovascular autonomic neuropathy in patients with type 2 diabetes
  Ji Eun Jun, Sang-Man Jin, Jongha Baek, Sewon Oh, Kyu Yeon Hur, Myung-Shik Lee, Moon-Kyu Lee, Jae Hyeon Kim
  Cardiovascular Diabetology.2015;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Longitudinal Changes in Insulin Resistance, Beta-Cell Function and Glucose Regulation Status in Prediabetes
  Chul-Hee Kim, Hong-Kyu Kim, Eun-Hee Kim, Sung-Jin Bae, Jaewon Choe, Joong-Yeol Park
  The American Journal of the Medical Sciences.2018; 355(1): 54.     CrossRef
• Association of serum 25-hydroxyvitamin D and diabetes-related factors in Korean adults without diabetes: The Fifth Korea National Health and Nutrition Examination Survey 2010–2012
  Hyunah Kim, Hyunyong Lee, Hyeon Woo Yim, Hun-Sung Kim
  Primary Care Diabetes.2018; 12(1): 59.     CrossRef
• Long‐term effects on glycaemic control and β‐cell preservation of early intensive treatment in patients with newly diagnosed type 2 diabetes: A multicentre randomized trial
  Suk Chon, Sang Youl Rhee, Kyu Jeung Ahn, Sei Hyun Baik, Yongsoo Park, Moon Suk Nam, Kwan Woo Lee, Soon Jib Yoo, Gwanpyo Koh, Dae Ho Lee, Young Seol Kim, Jeong‐Taek Woo
  Diabetes, Obesity and Metabolism.2018; 20(5): 1121.     CrossRef
• Four Plasma Glucose and Insulin Responses to a 75 g OGTT in Healthy Young Japanese Women
  Kei Takahashi, Hidetaka Nakamura, Hiroshi Sato, Hideto Matsuda, Kazuo Takada, Tomiko Tsuji
  Journal of Diabetes Research.2018; 2018: 1.     CrossRef
• Comparison of insulin intensification strategies with insulin lispro low mixture twice daily versus basal insulin glargine and prandial insulin lispro once daily in East Asian and Caucasian patients with type 2 diabetes mellitus
  In‐Kyung Jeong, Choon Hee Chung, Zhiguang Zhou, Jeong Hee Han, Ran Duan, Diana M. Edralin, Angel Rodriguez
  Journal of Diabetes.2017; 9(4): 396.     CrossRef
• Insulin Secretory Capacity and Insulin Resistance in Korean Type 2 Diabetes Mellitus Patients
  Jong-Dai Kim, Won-Young Lee
  Endocrinology and Metabolism.2016; 31(3): 354.     CrossRef
• Antisenescence activity of G9a inhibitor BIX01294 on human bone marrow mesenchymal stromal cells
  Min-Ji AHN, Sin-Gu JEONG, Goang-Won CHO
  TURKISH JOURNAL OF BIOLOGY.2016; 40: 443.     CrossRef
• Urinary N-acetyl-β-D-glucosaminidase, an early marker of diabetic kidney disease, might reflect glucose excursion in patients with type 2 diabetes
  So Ra Kim, Yong-ho Lee, Sang-Guk Lee, Eun Seok Kang, Bong-Soo Cha, Jeong-Ho Kim, Byung-Wan Lee
  Medicine.2016; 95(27): e4114.     CrossRef

Citations

Citations to this article as recorded by  

• Case report: Insulinomatosis: description of four sporadic cases and review of the literature
  Delmar Muniz Lourenço, Maria Lucia Corrêa-Giannella, Sheila Aparecida Coelho Siqueira, Marcia Nery, Flavio Galvão Ribeiro, Elizangela Pereira de Souza Quedas, Manoel de Souza Rocha, Ramon Marcelino do Nascimento, Maria Adelaide Albergaria Pereira
  Frontiers in Endocrinology.2024;[Epub]     CrossRef
• Insulin Autoimmune Syndrome: A Systematic Review
  MingXu Lin, YuHua Chen, Jie Ning, Tatsuya Kin
  International Journal of Endocrinology.2023; 2023: 1.     CrossRef
• Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS): Review of the Literature of a Rare Cause of Hyperinsulinemic Hypoglycemia
  Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, Hendrik Wiethoff, Albrecht Stenzinger, Manuel Röhrich, Uwe Pfeiffer, Wolfgang Rüdiger Kießling, Helena Engel, Harald Sourij, Thorsten Steinberg, Pascal Tomakidi, Stefan Kopf, Julia Szendroedi
  Biomedicines.2023; 11(6): 1732.     CrossRef
• An Uncommon Cause of Recurrent Presyncope, Dizziness, and Tachycardia: A Case Report of Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS)
  Martin Philipp Dieterle, Ayman Husari, Sophie Nicole Prozmann, Hendrik Wiethoff, Albrecht Stenzinger, Manuel Röhrich, Uwe Pfeiffer, Wolfgang Rüdiger Kießling, Helena Engel, Harald Sourij, Thorsten Steinberg, Pascal Tomakidi, Stefan Kopf, Julia Szendroedi
  Biomedicines.2023; 11(6): 1741.     CrossRef
• An Uncommon Case of Recurrent Hypoglycemic Episodes in a Healthy Non-diabetic Male: Insulin Autoimmune Syndrome
  Kanwarpal K Dhaliwal, Gaurav Bector, Saurabh Arora, Amanpreet Singh, Sanjay Kalra
  Cureus.2023;[Epub]     CrossRef
• The After-Dinner Dip
  Caren G. Solomon, Gertrud L.G. Haverkamp, Richard G. Ijzerman, Jos Kooter, Yvonne H.M. Krul-Poel
  New England Journal of Medicine.2022; 386(22): 2130.     CrossRef
• Hirata's disease (insulin autoimmune syndrome) following envenomation by a common krait
  Subramanian Senthilkumaran, Stephen W. Miller, Harry F. Williams, Ponniah Thirumalaikolundusubramanian, Sakthivel Vaiyapuri, Ketan Patel
  Toxicon.2022; 219: 106923.     CrossRef
• Analysis of the clinical characteristics of insulin autoimmune syndrome induced by methimazole
  Linli Sun, Weijin Fang, Dan Yi, Wei Sun, Chunjiang Wang
  Journal of Clinical Pharmacy and Therapeutics.2021; 46(2): 470.     CrossRef
• Continuous glucose monitoring and Rituximab treatment in insulin autoimmune syndrome
  Hiya Boro, Uttio Gupta, Charandeep Singh, Rakhi Malhotra, Rajesh Khadgawat
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2021; 15(6): 102294.     CrossRef

• Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description

  
  Daniele Cappellani, Enrico Macchia, Alberto Falorni, Piero Marchetti
  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy.2020; Volume 13: 963.     CrossRef
• Nationwide survey of endogenous hyperinsulinemic hypoglycemia in Japan (2017–2018): Congenital hyperinsulinism, insulinoma, non‐insulinoma pancreatogenous hypoglycemia syndrome and insulin autoimmune syndrome (Hirata’s disease)
  Yuki Yamada, Kana Kitayama, Maki Oyachi, Shinji Higuchi, Rie Kawakita, Yutaka Kanamori, Tohru Yorifuji
  Journal of Diabetes Investigation.2020; 11(3): 554.     CrossRef
• Insulin Autoimmune Syndrome – A Case Series
  Hiya Boro, Uttio Gupta, Charandeep Singh, Rakhi Malhotra, Rajesh Khadgawat
  European Endocrinology.2020; 16(2): 168.     CrossRef
• Management of Insulin Autoimmune Hypoglycaemia: Single‐centre experience from Western India with systematic review of world literature
  Muniraj Patel, Ravikumar Shah, Swati Ramteke‐Jadhav, Virendra Patil, Shivendra Kumar Patel, Anurag Lila, Nalini Shah, Tushar Bandgar
  Clinical Endocrinology.2020; 92(5): 409.     CrossRef
• Is insulin intoxication still the perfect crime? Analysis and interpretation of postmortem insulin: review and perspectives in forensic toxicology
  Charline Bottinelli, Nathalie Cartiser, Fabien Bévalot, Laurent Fanton, Jérôme Guitton
  Critical Reviews in Toxicology.2020; 50(4): 324.     CrossRef
• Insulin autoimmune syndrome induced by exogenous insulin injection: a four-case series
  Yimin Shen, Xiaoxiao Song, Yuezhong Ren
  BMC Endocrine Disorders.2019;[Epub]     CrossRef
• An observational analysis of insulinoma from a single institution
  S Shao, Z Zeng, S Hu
  QJM: An International Journal of Medicine.2018; 111(4): 237.     CrossRef
• Anti-tuberculosis Treatment-Induced Insulin Autoimmune Syndrome
  Jung Suk Han, Han Ju Moon, Jin Seo Kim, Hong Il Kim, Cheol Hyeon Kim, Min Joo Kim
  The Ewha Medical Journal.2016; 39(4): 122.     CrossRef
• Spontaneous hypoglycemia: diagnostic evaluation and management
  Leelavathy Kandaswamy, Rajeev Raghavan, Joseph M. Pappachan
  Endocrine.2016; 53(1): 47.     CrossRef
• Hypoglycemia due to Insulin Autoimmune Syndrome: A rare cause not to be forgotten
  Sarah Alam, Maaz Ozair, Jamal Ahmad
  Journal of Clinical and Translational Endocrinology: Case Reports.2016; 2: 7.     CrossRef

Citations

Citations to this article as recorded by  

• Diabetic ketosis vs ketoacidosis as initial presentation of pediatric type 1 diabetes mellitus. Associated features and rate of progression during the first two years after diagnosis
  Aristeidis Giannakopoulos, Natasa Chrysanthakopoulou, Alexandra Efthymiadou, Dionisios Chrysis
  Journal of Diabetes and its Complications.2024; 38(1): 108667.     CrossRef
• Role of liver parameters in diabetes mellitus – a narrative review
  Sana Rafaqat, Aqsa Sattar, Amber Khalid, Saira Rafaqat
  Endocrine Regulations.2023; 57(1): 200.     CrossRef
• The Prevalence of Selective and Partial Immunoglobulin A Deficiency in Patients with Autoimmune Polyendocrinopathy
  Mahnaz Jamee, Mohammad Reza Alaei, Mehrnaz Mesdaghi, Shahab Noorian, Mehdi Moosavian, Elahe Dolatshahi, Habibeh Taghavi Kojidi, Zahra Chavoshzadeh, Mazdak Fallahi, Samaneh Parviz, Fatemeh Aghamahdi, Gholamreza Azizi
  Immunological Investigations.2022; 51(4): 778.     CrossRef
• Selective immunoglobulin A deficiency in children with diabetes mellitus: Data from a medical center in Ukraine
  Oksana Boyarchuk, Lesya Dobrovolska, Halyna Svystunovych, Elsayed Abdelkreem
  PLOS ONE.2022; 17(11): e0277273.     CrossRef
• Clinical heterogeneity among pediatric patients with autoimmune type 1 diabetes stratified by immunoglobulin deficiency
  Anna Hogendorf, Małgorzata Szymańska, Joanna Krasińska, Anna Baranowska‐Jaźwiecka, Marta Ancuta, Anna Charubczyk, Krystyna Wyka, Izabela Drozdz, Magdalena Sokolowska‐Gadoux, Joanna Zarebska, Arkadiusz Michalak, Agnieszka Szadkowska, Przemysława Jarosz‐Cho
  Pediatric Diabetes.2021; 22(5): 707.     CrossRef
• Levels of salivary immunoglobulin a and immunoglobulin G in type 2 diabetic patients
  OlatundeA Olayanju, Olabisi Bamidele, BolaJ Eseile, Chioma Udeh, GabrielN Odok, NnaemekaE Awah, IzuchukwuN Mba, FayeoforiM Abbiyesuku
  Nigerian Journal of Medicine.2021; 30(6): 665.     CrossRef
• Late-Onset T1DM and Older Age Predict Risk of Additional Autoimmune Disease
  Jing W. Hughes, Yicheng K. Bao, Maamoun Salam, Prajesh Joshi, C. Rachel Kilpatrick, Kavita Juneja, David Nieves, Victoria Bouhairie, Olivia J. Jordan, Erica C. Blustein, Garry S. Tobin, Janet B. McGill
  Diabetes Care.2019; 42(1): 32.     CrossRef
• Circulating B cells in type 1 diabetics exhibit fewer maturation-associated phenotypes
  Patrick Hanley, Jennifer A. Sutter, Noah G. Goodman, Yangzhu Du, Debora R. Sekiguchi, Wenzhao Meng, Michael R. Rickels, Ali Naji, Eline T. Luning Prak
  Clinical Immunology.2017; 183: 336.     CrossRef

Citations

Citations to this article as recorded by  

• Muscle strength, an independent determinant of glycemic control in older adults with long-standing type 2 diabetes: a prospective cohort study
  Bo Kyung Koo, Seoil Moon, Min Kyong Moon
  BMC Geriatrics.2021;[Epub]     CrossRef
• Obesity Fact Sheet in Korea, 2019: Prevalence of Obesity and Abdominal Obesity from 2009 to 2018 and Social Factors
  Ga Eun Nam, Yang-Hyun Kim, Kyungdo Han, Jin-Hyung Jung, Eun-Jung Rhee, Seong-Su Lee, Dae Jung Kim, Kwan-Woo Lee, Won-Young Lee
  Journal of Obesity & Metabolic Syndrome.2020; 29(2): 124.     CrossRef
• Letter: Projection of Diabetes Prevalence in Korean Adults for the Year 2030 Using Risk Factors Identified from National Data (Diabetes Metab J 2019;43:90–6)
  Bo Kyung Koo
  Diabetes & Metabolism Journal.2019; 43(2): 242.     CrossRef
• Lower Leg Fat Depots Are Associated with Albuminuria Independently of Obesity, Insulin Resistance, and Metabolic Syndrome (Korea National Health and Nutrition Examination Surveys 2008 to 2011)
  Eugene Han, Nan Hee Cho, Mi Kyung Kim, Hye Soon Kim
  Diabetes & Metabolism Journal.2019; 43(4): 461.     CrossRef
• The Differential Association between Muscle Strength and Diabetes Mellitus According to the Presence or Absence of Obesity
  Bo Kyung Koo
  Journal of Obesity & Metabolic Syndrome.2019; 28(1): 46.     CrossRef
• Association of hearing impairment with insulin resistance, β–cell dysfunction and impaired fasting glucose before onset of diabetes
  M. Seo, Y.‐S. Lee, S.‐S. Moon
  Diabetic Medicine.2016; 33(9): 1275.     CrossRef
• Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA)
  Mats Martinell, Mozhgan Dorkhan, Jan Stålhammar, Petter Storm, Leif Groop, Carin Gustavsson
  Journal of Diabetes and its Complications.2016; 30(8): 1456.     CrossRef
• Are We in the Same Risk of Diabetes Mellitus? Gender- and Age-Specific Epidemiology of Diabetes in 2001 to 2014 in the Korean Population
  Bo Kyung Koo, Min Kyong Moon
  Diabetes & Metabolism Journal.2016; 40(3): 175.     CrossRef
• Relative and combined effects of socioeconomic status and diabetes on mortality
  Nam Hoon Kim, Tae Joon Kim, Nan Hee Kim, Kyung Mook Choi, Sei Hyun Baik, Dong Seop Choi, Yousung Park, Sin Gon Kim
  Medicine.2016; 95(30): e4403.     CrossRef
• Assessment of Lifestyle Risk Factors in Female Citizens of Saudi-Arabia with Type 2 Diabetes: Dietary Factors and Physical Activity
  Hans Hauner
  Journal of Diabetes, Metabolic Disorders & Control.2016;[Epub]     CrossRef

Citations

Citations to this article as recorded by  

• Triglyceride-glucose index predicts type 2 diabetes mellitus more effectively than oral glucose tolerance test-derived insulin sensitivity and secretion markers
  Min Jin Lee, Ji Hyun Bae, Ah Reum Khang, Dongwon Yi, Mi Sook Yun, Yang Ho Kang
  Diabetes Research and Clinical Practice.2024; 210: 111640.     CrossRef
• Pancreatic fat accumulation is associated with decreased β‐cell function and deterioration in glucose tolerance in Korean adults
  Sang Ouk Chin, You‐Cheol Hwang, In‐Jin Cho, In‐Kyung Jeong, Kyu Jeung Ahn, Ho Yeon Chung
  Diabetes/Metabolism Research and Reviews.2021;[Epub]     CrossRef
• Indirect insulin resistance detection: Current clinical trends and laboratory limitations
  Sylwia Placzkowska, Lilla Pawlik-Sobecka, Izabela Kokot, Agnieszka Piwowar
  Biomedical Papers.2019; 163(3): 187.     CrossRef
• Clinical Implications of Using Post-Challenge Plasma Glucose Levels for Early Diagnosis of Type 2 Diabetes Mellitus in Older Individuals
  Kyong Hye Joung, Sang Hyun Ju, Ji Min Kim, Sorim Choung, Jae Min Lee, Kang Seo Park, Hyun Jin Kim, Bon Jeong Ku
  Diabetes & Metabolism Journal.2018; 42(2): 147.     CrossRef
• The 1-h post-load plasma glucose as a novel biomarker for diagnosing dysglycemia
  Ram Jagannathan, Martin Buysschaert, José Luis Medina, Karin Katz, Sarah Musleh, Brenda Dorcely, Michael Bergman
  Acta Diabetologica.2018; 55(6): 519.     CrossRef
• Elevated 1‐hour post‐load plasma glucose identifies obese youth with abnormal glucose metabolism and an unfavourable inflammatory profile
  Anastasios Serbis, Vasileios Giapros, Anna Challa, Nikolaos Chaliasos, Ekaterini Siomou
  Clinical Endocrinology.2018; 89(6): 757.     CrossRef
• One‐hour postload plasma glucose concentration in people with normal glucose homeostasis predicts future diabetes mellitus: a 12‐year community‐based cohort study
  Tae Jung Oh, Soo Lim, Kyoung Min Kim, Jae Hoon Moon, Sung Hee Choi, Young Min Cho, Kyong Soo Park, HakChul Jang, Nam H. Cho
  Clinical Endocrinology.2017; 86(4): 513.     CrossRef
• An elevated 1-h post- load glucose level during the oral glucose tolerance test detects prediabetes
  Martin Buysschaert, Michael Bergman, Donald Yanogo, Ram Jagannathan, Benoit Buysschaert, Vanessa Preumont
  Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2017; 11(2): 137.     CrossRef
• Delayed insulin secretion response during an OGTT is associated with an increased risk for incidence of diabetes in NGT subjects
  Yun Sun, Junfeng Han, Ziwei Lin, Lige Song, Chen Wang, Weiping Jia
  Journal of Diabetes and its Complications.2016; 30(8): 1537.     CrossRef
• Postprandial Hyperglycemia
  Tae Jung Oh
  The Journal of Korean Diabetes.2016; 17(4): 233.     CrossRef
• β-Cell Function and Insulin Sensitivity in Normal Glucose-Tolerant Subjects Stratified by 1-Hour Plasma Glucose Values
  Miranda M. Priya, Anandakumar Amutha, T.A. Pramodkumar, Harish Ranjani, Saravanan Jebarani, Kuppan Gokulakrishnan, Rajendra Pradeepa, Ranjit Unnikrishnan, Ranjit Mohan Anjana, Viswanathan Mohan
  Diabetes Technology & Therapeutics.2016; 18(1): 29.     CrossRef
• Response: Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance (Diabetes Metab J2015;39:147-53)
  Tae Jung Oh, Se Hee Min, Chang Ho Ahn, Eun Ky Kim, Soo Heon Kwak, Hye Seung Jung, Kyong Soo Park, Young Min Cho
  Diabetes & Metabolism Journal.2015; 39(3): 270.     CrossRef
• Letter: Normal Glucose Tolerance with a High 1-Hour Postload Plasma Glucose Level Exhibits Decreased β-Cell Function Similar to Impaired Glucose Tolerance (Diabetes Metab J2015;39:147-53)
  Hee Kyung Kim
  Diabetes & Metabolism Journal.2015; 39(3): 268.     CrossRef

Citations

Citations to this article as recorded by  

• Effectiveness of the SUGAR intervention on hypoglycaemia in elderly patients with type 2 diabetes: A pragmatic randomised controlled trial
  Huda Y. Almomani, Carlos Rodriguez Pascual, Paul Grassby, Keivan Ahmadi
  Research in Social and Administrative Pharmacy.2023; 19(2): 322.     CrossRef
• A Cross-Sectional study on risk factors for severe hypoglycemia among Insulin-Treated elderly type 2 diabetes Mellitus (T2DM) patients in Singapore
  Michelle Shi Min Ko, Wai Kit Lee, Li Chang Ang, Su-Yen Goh, Yong Mong Bee, Ming Ming Teh
  Diabetes Research and Clinical Practice.2022; 185: 109236.     CrossRef
• Management Status of Patients with Type 2 Diabetes Mellitus at General Hospitals in Korea: A 5-Year Follow-Up Study
  Jin Hee Jung, Jung Hwa Lee, Hyang Mi Jang, Young Na, Hee Sun Choi, Yeon Hee Lee, Yang Gyo Kang, Na Rae Kim, Jeong Rim Lee, Bok Rye Song, Kang Hee Sim
  The Journal of Korean Diabetes.2022; 23(1): 64.     CrossRef
• Anti-hyperglycemic Medication Compliance: A Quality Assurance Project
  Rayan Mamoon, Md Y Mamoon, Debbie Hermanstyne, Issac Sachmechi
  Cureus.2022;[Epub]     CrossRef
• Randomised controlled trial of pharmacist-led patient counselling in controlling hypoglycaemic attacks in older adults with type 2 diabetes mellitus (ROSE-ADAM): A study protocol of the SUGAR intervention
  Huda Y. Almomani, Carlos Rodriguez Pascual, Sayer I. Al-Azzam, Keivan Ahmadi
  Research in Social and Administrative Pharmacy.2021; 17(5): 885.     CrossRef
• Severe hypoglycemia as a preventable risk factor for cardiovascular disease in patients with type 2 diabetes mellitus
  Soo-Yeon Choi, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2021; 36(2): 263.     CrossRef
• Type 2 diabetes patients’ views on prevention of hypoglycaemia – a mixed methods study investigating self-management issues and self-identified causes of hypoglycaemia
  Stijn Crutzen, Tessa van den Born-Bondt, Petra Denig, Katja Taxis
  BMC Family Practice.2021;[Epub]     CrossRef
• Cross‐sectional analysis of emergency hypoglycaemia and outcome predictors among people with diabetes in an urban population
  Chukwuma Uduku, Valentina Pendolino, Ian Godsland, Nick Oliver, Monika Reddy, Rachael T. Fothergill
  Diabetic Medicine.2021;[Epub]     CrossRef
• Short-term efficacy of high intensity group and individual education in patients with type 2 diabetes: a randomized single-center trial
  R. Reale, A. Tumminia, L. Romeo, N. La Spina, R. Baratta, G. Padova, L. Tomaselli, L. Frittitta
  Journal of Endocrinological Investigation.2019; 42(4): 403.     CrossRef
• The role of structured education in the management of hypoglycaemia
  Ahmed Iqbal, Simon R. Heller
  Diabetologia.2018; 61(4): 751.     CrossRef
• Association of diabetes therapy-related quality of life and physical activity levels in patients with type 2 diabetes receiving medication therapy: the Diabetes Distress and Care Registry at Tenri (DDCRT 17)
  Yasuaki Hayashino, Satoru Tsujii, Hitoshi Ishii
  Acta Diabetologica.2018; 55(2): 165.     CrossRef
• Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu-Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  Diabetes & Metabolism Journal.2017; 41(5): 367.     CrossRef
• Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  Diabetes & Metabolism Journal.2017; 41(5): 337.     CrossRef
• Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
  Byung-Wan Lee, Jin Hwa Kim, Seung-Hyun Ko, Kyu Yeon Hur, Nan-Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok-O Park, Kyung Mook Choi
  The Korean Journal of Internal Medicine.2017; 32(6): 967.     CrossRef
• Physician-Directed Diabetes Education without a Medication Change and Associated Patient Outcomes
  Hun-Sung Kim, Hyunah Kim, Hae-Kyung Yang, Eun Young Lee, Yoo Jin Jeong, Tong Min Kim, So Jung Yang, Seo Yeon Baik, Seung-Hwan Lee, Jae Hyoung Cho, In Young Choi, Hyeon Woo Yim, Bong-Yun Cha
  Diabetes & Metabolism Journal.2017; 41(3): 187.     CrossRef
• Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
  Seung-Hyun Ko, Kyu-Yeon Hur, Sang Youl Rhee, Nan-Hee Kim, Min Kyong Moon, Seok-O Park, Byung-Wan Lee, Hyun Jin Kim, Kyung Mook Choi, Jin Hwa Kim
  The Korean Journal of Internal Medicine.2017; 32(6): 947.     CrossRef
• Hypoglycemia and Health Costs
  Yong-ho Lee, Gyuri Kim, Eun Seok Kang
  The Journal of Korean Diabetes.2016; 17(1): 11.     CrossRef
• Association between estimated blood glucose levels and glycated hemoglobin levels
  Seon-Ah Cha, Seung-Hyun Ko
  The Korean Journal of Internal Medicine.2016; 31(3): 457.     CrossRef
• Characteristics of Hypoglycemia Pateints Visiting the Emergency Department of a University Hospital
  Sang-Hyeon Choi, Deok-Ki Youn, Moon-Gi Choi, Ohk-Hyun Ryu
  The Journal of Korean Diabetes.2016; 17(3): 202.     CrossRef
• Experiences of Diabetes Education among Educators of Diabetes : a content analysis approach
  Soo Jin Kang, Soo Jung Chang
  Journal of Korean Public Health Nursing.2016; 30(2): 221.     CrossRef

Citations

Citations to this article as recorded by  

• Glycemic dispersion: a new index for screening high glycemic variability
  Rui Shi, Lei Feng, Yan-Mei Liu, Wen-Bo Xu, Bei-Bei Luo, Ling-Tong Tang, Qian-Ye Bi, Hui-Ying Cao
  Diabetology & Metabolic Syndrome.2023;[Epub]     CrossRef
• Digital Behavior Change Interventions to Reduce Sedentary Behavior and Promote Physical Activity in Adults with Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Xiaoyan Zhang, Xue Qiao, Ke Peng, Shan Gao, Yufang Hao
  International Journal of Behavioral Medicine.2023;[Epub]     CrossRef
• DBS are suitable for 1,5-anhydroglucitol monitoring in GSD1b and G6PC3-deficient patients taking SGLT2 inhibitors to treat neutropenia
  Joseph P. Dewulf, Nathalie Chevalier, Sandrine Marie, Maria Veiga-da-Cunha
  Molecular Genetics and Metabolism.2023; 140(3): 107712.     CrossRef
• The correlation between serum 1, 5-anhydroglucitol and β-cell function in Chinese adults with different glucose metabolism statuses
  Yuexing Yuan, Yuanyuan Tan, Yao Wang, Shanhu Qiu, Jiao Yang, Cheng Chen
  International Journal of Diabetes in Developing Countries.2023;[Epub]     CrossRef
• HbA1c combined with glycated albumin or 1,5‐anhydroglucitol improves the efficiency of diabetes screening in a Chinese population
  Junyi Qian, Cheng Chen, Xiaohang Wang, Yuanyuan Tan, Jiao Yang, Yuexing Yuan, Juan Chen, Haijian Guo, Bei Wang, Zilin Sun, Yao Wang
  Diabetic Medicine.2022;[Epub]     CrossRef
• Assessment of glycemia in chronic kidney disease
  Mohamed Hassanein, Tariq Shafi
  BMC Medicine.2022;[Epub]     CrossRef
• Continuous subcutaneous insulin infusion alters microRNA expression and glycaemic variability in children with type 1 diabetes
  Emma S. Scott, Andrzej S. Januszewski, Luke M. Carroll, Gregory R. Fulcher, Mugdha V. Joglekar, Anandwardhan A. Hardikar, Timothy W. Jones, Elizabeth A. Davis, Alicia J. Jenkins
  Scientific Reports.2021;[Epub]     CrossRef
• Red rice koji extract alleviates hyperglycemia by increasing glucose uptake and glucose transporter type 4 levels in skeletal muscle in two diabetic mouse models
  Takakazu Yagi, Koji Ataka, Kai-Chun Cheng, Hajime Suzuki, Keizaburo Ogata, Yumiko Yoshizaki, Kazunori Takamine, Ikuo Kato, Shouichi Miyawaki, Akio Inui, Akihiro Asakawa
  Food & Nutrition Research.2020;[Epub]     CrossRef
• How tightly controlled do fluctuations in blood glucose levels need to be to reduce the risk of developing complications in people with Type 1 diabetes?
  R. Livingstone, J. G. Boyle, J. R. Petrie
  Diabetic Medicine.2020; 37(4): 513.     CrossRef
• Resolution on the results of the first working meeting of the scientific advisory board «Actual problems of glycemic variability as a new criterion of glycemic control and safety of diabetes therapy»
  Mikhail B. Antsiferov, Gagik R. Galstyan, Alexey V. Zilov, Alexander Y. Mayorov, Tatyana N. Markova, Nikolay A. Demidov, Olga M. Koteshkova, Dmitry N. Laptev, Alisa V. Vitebskaya
  Diabetes mellitus.2019; 22(3): 281.     CrossRef
• Hyperglycemia and Carotenoid Intake Are Associated with Serum Carotenoids in Youth with Type 1 Diabetes
  Namrata Sanjeevi, Leah M. Lipsky, Tonja R. Nansel
  Journal of the Academy of Nutrition and Dietetics.2019; 119(8): 1340.     CrossRef
• Correlation of Serum 1,5-AG with Uric Acid in Type 2 Diabetes Mellitus with Different Renal Functions
  Kai Zhang, Bizhen Xue, Yuexing Yuan, Yao Wang
  International Journal of Endocrinology.2019; 2019: 1.     CrossRef
• Glycaemic control and glycaemic variability in older people with diabetes
  Hermes J Florez
  The Lancet Diabetes & Endocrinology.2018; 6(6): 433.     CrossRef
• Alternate glycemic markers reflect glycemic variability in continuous glucose monitoring in youth with prediabetes and type 2 diabetes
  Christine L. Chan, Laura Pyle, Megan M. Kelsey, Lindsey Newnes, Amy Baumgartner, Philip S. Zeitler, Kristen J. Nadeau
  Pediatric Diabetes.2017; 18(7): 629.     CrossRef
• 1,5-anidroglucitolo: un marcatore non tradizionale di iperglicemia
  Gabriella Lavalle, Roberto Testa, Maria Elisabetta Onori, Raffaella Vero, Anna Vero
  La Rivista Italiana della Medicina di Laboratorio - Italian Journal of Laboratory Medicine.2017; 13(3-4): 139.     CrossRef
• Glycemic control and variability in association with body mass index and body composition over 18months in youth with type 1 diabetes
  Leah M. Lipsky, Benjamin Gee, Aiyi Liu, Tonja R. Nansel
  Diabetes Research and Clinical Practice.2016; 120: 97.     CrossRef
• How Can We Easily Measure Glycemic Variability in Diabetes Mellitus?
  Suk Chon
  Diabetes & Metabolism Journal.2015; 39(2): 114.     CrossRef
• Alternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitol
  Ji-Eun Lee
  Annals of Pediatric Endocrinology & Metabolism.2015; 20(2): 74.     CrossRef
• Glycemic Variability: How Do We Measure It and Why Is It Important?
  Sunghwan Suh, Jae Hyeon Kim
  Diabetes & Metabolism Journal.2015; 39(4): 273.     CrossRef